Expected Blood Loss in Severe Hemorrhagic Shock

Clinical Assessment of Blood Loss

The American College of Surgeons Advanced Trauma Life Support (ATLS) classification provides a standardized approach to estimating blood loss based on initial presentation, with Class I being up to 15% blood volume loss, Class II being 15-30%, Class III being 30-40%, and Class IV being greater than 40% blood volume loss 1, 2, 3
Class I hemorrhagic shock is characterized by a pulse rate <100 beats/min, normal blood pressure, normal pulse pressure, normal urine output (>30 mL/h), and slightly anxious mental status 3
Class II hemorrhagic shock is characterized by a pulse rate 100-120 beats/min, normal blood pressure, decreased pulse pressure, urine output 20-30 mL/h, and mildly anxious mental status 1, 2, 3
Class III hemorrhagic shock is characterized by a pulse rate 120-140 beats/min, decreased blood pressure, decreased pulse pressure, urine output 5-15 mL/h, and anxious and confused mental status 1, 2, 3
Class IV hemorrhagic shock is characterized by a pulse rate >140 beats/min, decreased blood pressure, decreased pulse pressure, negligible urine output, and confused and lethargic mental status 1, 2, 3, 4

A patient with a pulse of 130 beats/min, blood pressure of 84/46 mmHg, base deficit of -8 mEq/L, and negligible urine output is consistent with Class IV hemorrhagic shock, with an estimated blood loss exceeding 40% of blood volume (>2000 mL) 1, 2, 3, 5

Base deficit is a sensitive marker for estimating the extent of bleeding and shock, with a base deficit between -6 to -9 mEq/L classified as moderate and correlating with significant blood loss 4, 5, 6

The ATLS categorizes patients based on their response to initial fluid resuscitation, with a "minimal or no response" pattern indicating a high need for crystalloid and immediate blood transfusion, and a likely need for operative intervention 1, 2, 3

Patients with Class IV hemorrhagic shock require immediate interventions, including immediate blood product transfusion, aggressive crystalloid resuscitation, urgent surgical intervention for hemorrhage control, and consideration of early use of tranexamic acid 1, 2, 3
Monitoring should include serial lactate or base deficit measurements, hemodynamic parameters, urine output, and coagulation status, as severe hemorrhage often leads to coagulopathy 1, 2, 3, 5, 6

Relying solely on blood pressure for assessment, as compensatory mechanisms may maintain pressure despite significant blood loss, and overlooking base deficit as an important marker of tissue hypoperfusion 4, 5, 6
Delaying blood product administration in severe hemorrhagic shock, and excessive crystalloid administration, which may worsen coagulopathy and hemodilution 3, 7